Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
Thursday, August 26, 2021
Comment
Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.
from NDTV Profit - Latest https://ift.tt/2Ws5lao
from NDTV Profit - Latest https://ift.tt/2Ws5lao
0 Response to "Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug"
Post a Comment